Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Why CEL-SCI Shares Are Getting Hammered Today

CEL-SCI Corporation (NASDAQ: CVM) shares are trading lower by 27% at $9.33 on continued downward momentum following data from a Phase 3 Study of Multkine showing a 14.1% 5-year survival benefit in groups receiving surgery and radiotherapy for cancer.
byHenry Khederian
June 30, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

CEL-SCI Corporation (NASDAQ:CVM) shares are trading lower by 27% at $9.33 on continued downward momentum following data from a Phase 3 Study of Multkine showing a 14.1% 5-year survival benefit in groups receiving surgery and radiotherapy for cancer.

CEL-SCI is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases.

CEL-SCI has a 52-week high of $40.91 and a 52-week low of $9.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

US Stock Futures Down Ahead Of Powell, PMI Data; Crude Oil Falls Sharply

By Lisa Levin
September 23, 5:10 AM
Pre-open movers U.S. stock futures traded lower in early pre-market trade on Friday after recording losses on Thursday. The Dow Jones closed lower by more than 100 points, while the Nasdaq Composite fell around 150 points in the previous session after the US Federal Reserve, on Wednesday, raised its policy rate by 75 basis points for the third time.

AIR